Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 251

1.

Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images.

Barisoni L, Troost JP, Nast C, Bagnasco S, Avila-Casado C, Hodgin J, Palmer M, Rosenberg A, Gasim A, Liensziewski C, Merlino L, Chien HP, Chang A, Meehan SM, Gaut J, Song P, Holzman L, Gibson D, Kretzler M, Gillespie BW, Hewitt SM.

Mod Pathol. 2016 Apr 22. doi: 10.1038/modpathol.2016.58. [Epub ahead of print]

PMID:
27102348
2.

Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.

Simon N, Antignani A, Sarnovsky R, Hewitt SM, FitzGerald D.

J Natl Cancer Inst. 2016 Apr 13;108(8). pii: djw028. doi: 10.1093/jnci/djw028. Print 2016 Aug.

PMID:
27075852
3.

Reproducibility: It Is Just Good Science.

Hewitt SM.

J Histochem Cytochem. 2016 Apr;64(4):223. doi: 10.1369/0022155416636547. No abstract available.

PMID:
27029767
4.

Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL.

Breast Cancer Res. 2016 Feb 18;18(1):24. doi: 10.1186/s13058-016-0678-4.

5.

The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.

Dine JL, O'Sullivan CC, Voeller D, Greer YE, Chavez KJ, Conway CM, Sinclair S, Stone B, Amiri-Kordestani L, Merchant AS, Hewitt SM, Steinberg SM, Swain SM, Lipkowitz S.

Breast Cancer Res Treat. 2016 Jan;155(2):235-51. doi: 10.1007/s10549-015-3673-z. Epub 2016 Jan 12.

PMID:
26759246
6.

Time Advances, People and Language Change, but the Fundamentals Remain the Same.

Hewitt SM.

J Histochem Cytochem. 2016 Jan;64(1):5-6. doi: 10.1369/0022155415617744. No abstract available.

PMID:
26715364
7.

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.

Kim BW, Cho H, Choi CH, Ylaya K, Chung JY, Kim JH, Hewitt SM.

BMC Cancer. 2015 Dec 26;15:1015. doi: 10.1186/s12885-015-2015-1.

8.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

PMID:
26656320
9.

Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities.

Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, Johnson JM, Chicoine RE, Herschorn SD, Shepherd JA, Wang J, Malkov S, Vacek PM, Weaver DL, Fan B, Mahmoudzadeh AP, Palakal M, Xiang J, Oh H, Horne HN, Sprague BL, Hewitt SM, Brinton LA, Sherman ME.

Cancer Prev Res (Phila). 2016 Feb;9(2):149-58. doi: 10.1158/1940-6207.CAPR-15-0282. Epub 2015 Dec 8.

PMID:
26645278
10.

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

Zhu G, Liu Z, Epstein JI, Davis C, Christudass CS, Carter HB, Landis P, Zhang H, Chung JY, Hewitt SM, Miller MC, Veltri RW.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1864-72. doi: 10.1158/1055-9965.EPI-15-0496. Epub 2015 Sep 24.

PMID:
26404961
11.

Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.

Figueroa JD, Koutros S, Colt JS, Kogevinas M, Garcia-Closas M, Real FX, Friesen MC, Baris D, Stewart P, Schwenn M, Johnson A, Karagas MR, Armenti KR, Moore LE, Schned A, Lenz P, Prokunina-Olsson L, Banday AR, Paquin A, Ylaya K, Chung JY, Hewitt SM, Nickerson ML, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Malats N, Fraumeni JF Jr, Chanock SJ, Chatterjee N, Rothman N, Silverman DT.

J Natl Cancer Inst. 2015 Sep 14;107(11). pii: djv223. doi: 10.1093/jnci/djv223. Print 2015 Nov.

PMID:
26374428
12.

Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer.

Choi CH, Chung JY, Cho H, Kitano H, Chang E, Ylaya K, Chung EJ, Kim JH, Hewitt SM.

Pathobiology. 2015;82(5):203-11. doi: 10.1159/000434726. Epub 2015 Aug 25.

PMID:
26337566
13.

Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.

Naik HB, Steinberg SM, Middelton LA, Hewitt SM, Zuo RC, Linehan WM, Kong HH, Cowen EW.

JAMA Dermatol. 2015 Oct;151(10):1096-102. doi: 10.1001/jamadermatol.2015.1793.

PMID:
26244563
14.

Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Nast CC, Lemley KV, Hodgin JB, Bagnasco S, Avila-Casado C, Hewitt SM, Barisoni L.

Semin Nephrol. 2015 May;35(3):266-78. doi: 10.1016/j.semnephrol.2015.04.006. Review.

15.

PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.

Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, Cho H, Song J.

Nat Commun. 2015 Jul 17;6:7769. doi: 10.1038/ncomms8769.

16.

Evaluation environment for digital and analog pathology: a platform for validation studies.

Gallas BD, Gavrielides MA, Conway CM, Ivansky A, Keay TC, Cheng WC, Hipp J, Hewitt SM.

J Med Imaging (Bellingham). 2014 Oct;1(3):037501. doi: 10.1117/1.JMI.1.3.037501. Epub 2014 Nov 12.

17.

Cripto-1 as a novel therapeutic target for triple negative breast cancer.

Castro NP, Fedorova-Abrams ND, Merchant AS, Rangel MC, Nagaoka T, Karasawa H, Klauzinska M, Hewitt SM, Biswas K, Sharan SK, Salomon DS.

Oncotarget. 2015 May 20;6(14):11910-29.

18.

Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, Schott M, Chung L, He Q, Lambert P, Walker J, Newton MA, Wentzensen N, Ahlquist P.

Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3255-64. doi: 10.1073/pnas.1509322112. Epub 2015 Jun 8.

19.

Proteomic expressional profiling of a paraffin-embedded tissue by multiplex tissue immunoblotting.

Chung JY, Hewitt SM.

Methods Mol Biol. 2015;1312:175-84. doi: 10.1007/978-1-4939-2694-7_21.

PMID:
26044002
20.

A well-based reverse-phase protein array of formalin-fixed paraffin-embedded tissue.

Chung JY, Hewitt SM.

Methods Mol Biol. 2015;1312:129-39. doi: 10.1007/978-1-4939-2694-7_17.

PMID:
26043998
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk